Skip to main navigation
Tactile Medical
  • About Lymphedema
    • Overview
    • Signs & Symptoms
    • Treatment
    • Management
  • Products
    • Overview
    • FLEXITOUCH® system
    • Entre™ System
    • Actitouch® System
    • Clinical Evidence
  • Patients
    • Overview
    • Signs & Symptoms
    • Patient Testimonials
    • Lymphedema Partners
  • Healthcare Professionals
    • Overview
    • Health Plan Coverage
    • Veterans Affairs
    • Clinical Evidence
    • Professional Resources
    • Thought Leadership
  • Investors
    • News
    • Events & Webcasts
    • Stock Information
    • Annual Reports & SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Investor Contacts
  • About Us
    • Who We Are
    • Leadership
    • News
    • Careers
Patient Portal
Select Page

Investors

Investors

 
At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders

Copyright Nasdaq. Minimum 15 minutes delayed.


Q3 2019 Investor Presentation

Download

2017 Annual Report to Stockholders

Download

Sign up for Email Alerts

Learn More

Upcoming Events

More events are coming soon.

Recent News

November 13, 2019
Tactile Medical to Participate in Two Upcoming Investor Conferences in November and December
MINNEAPOLIS , Nov. 13, 2019 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the following
Read More »
November 4, 2019
Tactile Systems Technology, Inc. Reports Third Quarter 2019 Financial Results; Updates 2019 Outlook
Third Quarter Revenue Increased 37% Year-Over-Year; Operating Income Up 134% MINNEAPOLIS , Nov. 04, 2019 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases
Read More »
September 30, 2019
Tactile Medical to Release Third Quarter of Fiscal Year 2019 Financial Results on November 4, 2019
MINNEAPOLIS , Sept. 30, 2019 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that third quarter of fiscal year 2019 financial
Read More »
August 27, 2019
Tactile Medical to Present at Two Upcoming Investor Conferences in September and October
MINNEAPOLIS , Aug. 27, 2019 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the following
Read More »
View All News »
  • RSS Feeds
  • Email Alerts
  • Investor Contacts
  • Print Page
  • E-mail Page
Logo


Tactile Systems Technology, Inc. BBB Business Review
  • About Lymphedema
  • Products
  • Patients
  • Healthcare Professionals
  • Investors
  • About Us
  • Careers
  • Pay My Bill
  • Patient Contact Us
  • Clinician Contact Us
  • Forms
  • Media Resources
  • Privacy Statement
  • Terms & Conditions
  • Warranty & Return Policies
1331 Tyler Street NE, Suite 200
Minneapolis, MN 55413 USA

Phone: 612.355.5100
Toll-free: 866.435.3948
Fax: 866.435.3949
facebook linkedin twitter youTube
Flexitouch, Actitouch, Entre and HEALING RIGHT AT HOME are all trademarks or registered trademarks of Tactile Medical.
D/N500187-000-00 Rev. J 11/2017